Largest market shown
Germany
$200.6B calculated opportunity across 55 screened products.
Regional export playbook
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Europe regional view
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Largest market shown
$200.6B calculated opportunity across 55 screened products.
Regional footprint
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $200.6B | 55 | Not reported | 9,396 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| NetherlandsNLD | $111.0B | 26 | Not reported | 9,457 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| United KingdomGBR | $106.1B | 25 | Not reported | 9,790 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| Switzerland, LiechtensteinCHE | $82.5B | 10 | Not reported | 9,651 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FranceFRA | $62.2B | 20 | Not reported | 9,834 km | 4 | Vehicles: with only electric motor for propulsion |
| BelgiumBEL | $40.1B | 8 | Not reported | 9,587 km | 5 | Product not reported |
| SloveniaSVN | $39.0B | 6 | Not reported | 9,242 km | 8 | Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof |
| RussiaRUS | $36.5B | 8 | Not reported | 7,357 km | 10 | Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc |
| SpainESP | $26.3B | 12 | Not reported | 10,804 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| PolandPOL | $25.9B | 13 | Not reported | 8,512 km | 37 | Telephones for cellular networks or for other wireless networks |
| ItalyITA | $23.4B | 8 | Not reported | 9,614 km | 11 | Heterocyclic compounds: n.e.c. in headings no. 2933 |
| CzechiaCZE | $19.2B | 8 | Not reported | 9,028 km | 25 | Telephones for cellular networks or for other wireless networks |
| DenmarkDNK | $13.3B | 4 | Not reported | 8,836 km | 4 | Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas |
| AustriaAUT | $11.8B | 6 | Not reported | 9,004 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| IrelandIRL | $10.2B | 4 | Not reported | 9,962 km | 11 | Electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits |
| NorwayNOR | $5.7B | 2 | Not reported | 8,695 km | 4 | Vehicles: with only electric motor for propulsion |
| SlovakiaSVK | $4.8B | 3 | Not reported | 8,954 km | 22 | Telephones for cellular networks or for other wireless networks |
| SwedenSWE | $4.4B | 2 | Not reported | 8,358 km | 8 | Vehicles: with only electric motor for propulsion |
| HungaryHUN | $4.2B | 2 | Not reported | 8,861 km | 7 | Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 |
| RomaniaROU | $3.7B | 2 | Not reported | 0 km | 0 | Vehicles: parts, gear boxes |
| GreeceGRC | $1.5B | 1 | Not reported | 8,965 km | 4 | Electrical apparatus: photosensitive, including photovoltaic cells, whether or not assembled in modules or made up into panels, light emitting diodes |
| UkraineUKR | $1.4B | 1 | Not reported | 7,965 km | 7 | Product not reported |
Top regional opportunities
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | United KingdomGBR | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $26.2B | +15.3% | +0.0% |
| 3 | GermanyDEU | HS 850760Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.7B | +19.2% | +0.1% |
| 4 | NetherlandsNLD | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 5 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $17.3B | +12.8% | +0.0% |
| 6 | Switzerland, LiechtensteinCHE | HS 710813Metals: gold, semi-manufactured | $17.2B | +14.3% | +0.0% |
| 7 | GermanyDEU | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 8 | BelgiumBEL | HS 271019Product description unavailable | $12.8B | +9.1% | +0.3% |
| 9 | GermanyDEU | HS 271019Product description unavailable | $12.3B | +5.8% | +0.2% |
| 10 | RussiaRUS | HS 870323Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc | $12.3B | +12.7% | +0.0% |
| 11 | NetherlandsNLD | HS 271019Product description unavailable | $11.8B | +12.2% | +0.2% |
| 12 | SloveniaSVN | HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $11.3B | +34.8% | +0.0% |
| 13 | SloveniaSVN | HS 293399Heterocyclic compounds: n.e.c. in headings no. 2933 | $10.5B | +30.0% | +0.0% |
| 14 | United KingdomGBR | HS 870380Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 15 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 16 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $9.3B | +9.2% | +2.4% |
| 17 | GermanyDEU | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $9.0B | +4.4% | +0.0% |
| 18 | RussiaRUS | HS 870322Vehicles: with only spark-ignition internal combustion piston engine, cylinder capacity over 1000 but not over 1500cc | $8.5B | +16.6% | +0.0% |
| 19 | GermanyDEU | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.1B | +3.5% | +2.5% |
| 20 | BelgiumBEL | HS 300220Vaccines: for human medicine | $8.0B | +20.4% | +0.0% |
Sector opportunities
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 30
38 screened products with $305.6B of reported buyer imports.
$149.3BCalculated opportunity · +12.0% average growthHS2 85
39 screened products with $200.8B of reported buyer imports.
$126.6BCalculated opportunity · +12.8% average growthHS2 87
39 screened products with $224.3B of reported buyer imports.
$122.0BCalculated opportunity · +19.0% average growthHS2 00
22 screened products with $201.4B of reported buyer imports.
$88.5BCalculated opportunity · +8.1% average growthHS2 71
12 screened products with $220.0B of reported buyer imports.
$82.9BCalculated opportunity · +10.3% average growthHS2 84
21 screened products with $101.2B of reported buyer imports.
$70.8BCalculated opportunity · +9.4% average growthHS2 27
11 screened products with $134.8B of reported buyer imports.
$64.1BCalculated opportunity · +18.7% average growthHS2 29
9 screened products with $41.6B of reported buyer imports.
$47.0BCalculated opportunity · +20.4% average growthFrequently asked questions
Practical guidance for interpreting regional market and product comparisons.
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.